Indication

Pseudomonas aeruginosa urinary tract infection

A *Pseudomonas aeruginosa* urinary tract infection is an opportunistic bacterial infection of the urinary tract caused by the Gram-negative, aerobic bacillus *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa urinary tract infection

159 drugs 86 manufacturers

Advertisement

Drugs that treat it

Common Pseudomonas aeruginosa urinary tract infection therapies.

Showing 28–36 of 159 drugs

Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa urinary tract infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pseudomonas aeruginosa urinary tract infection.

A *Pseudomonas aeruginosa* urinary tract infection is an opportunistic bacterial infection of the urinary tract caused by the Gram-negative, aerobic bacillus *Pseudomonas aeruginosa*.

It predominantly affects hospitalized, institutionalized, or immunocompromised patients, particularly those with indwelling urinary catheters, urinary tract instrumentation, anatomic abnormalities, or prior broad-spectrum antimicrobial exposure.

Clinical manifestations range from lower urinary tract symptoms, such as dysuria, urgency, and pelvic pain, to upper tract involvement presenting with fever, flank pain, or life-threatening urosepsis.

Pathophysiologically, the organism establishes infection via prominent biofilm formation on urothelial surfaces and foreign materials, coupled with intrinsic and acquired multidrug resistance mechanisms that impede immune clearance and conventional antimicrobial eradication.

Personalize your experience

Follow Pseudomonas aeruginosa urinary tract infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it